st 1435 has been researched along with Cerebral Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fréchou, M; Guennoun, R; Kumar, N; Mattern, C; Schumacher, M; Sitruk-Ware, R; Zhu, X | 1 |
| Ogaeri, T; Samsonov, M; Sokabe, M; Tanaka, M | 1 |
2 other study(ies) available for st 1435 and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Sex differences in the cerebroprotection by Nestorone intranasal delivery following stroke in mice.
Topics: Administration, Intranasal; Animals; Behavior, Animal; Brain; Female; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Ischemic Stroke; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; Norprogesterones; Receptors, Progesterone; Sex Characteristics; Treatment Outcome | 2021 |
Nestorone exerts long-term neuroprotective effects against transient focal cerebral ischemia in adult male rats.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Neuroprotection; Neuroprotective Agents; Norprogesterones; Progesterone; Rats; Rats, Sprague-Dawley; Stroke | 2019 |